⌄
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
10:20 | 10:50 | 1. Syncope |
10:50 | 11:20 | 2. Altered level of consciousness |
11:20 | 11:50 | 3. Hypoxemia |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Appendicitis: pearls and pitfalls |
10:50 | 11:20 | 2. Testicular and fallopian tube torsion |
11:20 | 11:50 | 3. Intestinal intussusception. From typical to unexpected |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Dengue |
10:50 | 11:20 | 2. Yellow fever |
11:20 | 11:50 | 3. Chikungunya and Oropouche fever |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Risk map. How to improve quality and safety |
10:50 | 11:20 | 2. Emergency room dashboard. Which indicators should we mesure? |
11:20 | 11:50 | 3. Medication errors |
11:50 | 12:20 | 4. Q & A |
14:20 | 14:40 | 1. Inhalational treatment: Beta-agonist and Ipratropium Bromide |
14:40 | 15:00 | 2. Systemic and inhaled corticosteroid therapy |
15:00 | 15:20 | 3. Intravenous treatment |
15:20 | 15:40 | 4. Ventilatory support |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Apneic oxygenation in rapid sequence intubation |
14:40 | 15:00 | 2. Rapid sequence intubation |
15:00 | 15:20 | 3. Airway access and salvage devices |
15:20 | 15:40 | 4. Difficult airway |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Initial care |
14:40 | 15:00 | 2. Fluid therapy |
15:00 | 15:20 | 3. Use of blood components |
15:20 | 15:40 | 4. Role of ultrasound |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Is mild sedation appropriate in any context? |
14:40 | 15:00 | 2. Difficult-to-sedate patient |
15:00 | 15:20 | 3. Difficult to understand patient. How to access a patient with intelectual disability? |
15:20 | 15:40 | 4. Multimodal analgesia for pediatric urgencies |
15:40 | 16:10 | 5. Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
10:20 | 10:50 | 1.Invasive bacterial infections in febrile infant ages 2 to 6 months. |
10:50 | 11:20 | 2. Role of molecular viral and bacterial diagnosis |
11:20 | 11:50 | 3. Biomarkers in febrile illness |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1.Cervical trauma |
10:50 | 11:20 | 2. Thoracic trauma |
11:20 | 11:50 | 3. Abdominal trauma |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Highly toxic substances in children |
10:50 | 11:20 | 2. From the clue to the antidote |
11:20 | 11:50 | 3. Poisonings that require intubation |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Acute myocarditis |
10:50 | 11:20 | 2. Adrenal shock |
11:20 | 11:50 | 3. FPIES |
11:50 | 12:20 | 4. Q & A |
14:20 | 14:40 | 1.Differential diagnosis in the emergency room |
14:40 | 15:00 | 2. First-line drugs. Indications, routes of administration, and drug resistance |
15:00 | 15:20 | 3. Second-line therapy |
15:20 | 15:40 | 4. Refractory status epilepticus. Clinical and pharmacological management |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Fluid therapy |
14:40 | 15:00 | 2. Insulin therapy |
15:00 | 15:20 | 3. Life-threatening electrolyte disorders |
15:20 | 15:40 | 4. Cerebral Edema |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Airway management and ventilation |
14:40 | 15:00 | 2. Pharmacotherapy |
15:00 | 15:20 | 3. Immediate post-CPR care |
15:20 | 15:40 | 4. Role of ultrasound |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Pediatric trauma versus adult trauma |
14:40 | 15:00 | 2. Post-trauma CPR |
15:00 | 15:20 | 3. Treatment of coagulopathy |
15:20 | 15:40 | 4. Human factors. What is outside the algorithms |
15:40 | 16:10 | 5. Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
08:50 | 09:20 | Presentation |
09:20 | 10:00 | Q & A |
10:20 | 10:50 | 1. Bacterial pneumonia and complications |
10:50 | 11:20 | 2. Atypical Pneumonia |
11:20 | 11:50 | 3. Role of ultrasound |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Tools for early detection of sepsis and septic shock |
10:50 | 11:20 | 2. PECARN: prompt bolus study |
11:20 | 11:50 | 3. The first hour of a child with sepsis and septic shock |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:50 | 1. Poisoning by new psychoative drugs in adolescentes |
10:50 | 11:20 | 2. The role of digestive decontamination |
11:20 | 11:50 | 3. Liver injury and metabolic acidosis in the poisoned patient |
11:50 | 12:20 | 4. Q & A |
10:20 | 10:35 | 1. North America |
10:35 | 10:50 | 2. Africa |
10:50 | 11:05 | 3. LATAM |
11:05 | 11:20 | 4. Europe |
11:20 | 11:35 | 5. Australia and the Pacific |
11:35 | 11:50 | 6. Asia |
11:50 | 12:20 | 7. Q & A |
14:20 | 14:40 | 1. Definition and oxygen therapy |
14:40 | 15:00 | 2. Inhalation treatment: beta-agonists and hypertonic solution |
15:00 | 15:20 | 3. Other treatments |
15:20 | 15:40 | 4. Vaccination impact |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Fluid resuscitation |
14:40 | 15:00 | 2. Inotropes and vasopressors |
15:00 | 15:20 | 3. Monitoring |
15:20 | 15:40 | 4. Role of ultrasound |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Preparation and monitoring |
14:40 | 15:00 | 2. In minor procedures |
15:00 | 15:20 | 3. In major procedures |
15:20 | 15:40 | 4. Importance of protocols in the ED |
15:40 | 16:10 | 5. Q & A |
14:20 | 14:40 | 1. Submersion injury |
14:40 | 15:00 | 2. Electrocution injury |
15:00 | 15:20 | 3. Burn |
15:20 | 15:40 | 4. Hypothermia |
15:40 | 16:10 | 5. Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |
16:30 | 17:00 | Presentation |
17:00 | 17:40 | Q & A |